A study to find out the effectiveness of Homoeopathic medicines in Allergic asthma patients

A CLINICAL STUDY TO FIND OUT THE CHANGES IN PULMONARY FUNCTION TEST IN ALLERGIC BRONCHIAL ASTHMA WITH INDIVIDUALISED HOMOEOPATHIC MEDICINE

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046524

Enrollment

Registered

2022-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: HOMOEPATHIC MEDICINE: A clinical study in allergic bronchial asthma patients to find out the changes in pulmonary function test by using homoeopathic medicines. ROUTE OF ADMINISTRATION-

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with age 18- 60 years of any gender. 2. Patients with reduction in FEV1 / FVC Ratio ( below 70 %) 3. Patient with increased serum IgE level. 4. Patient with signs and symptoms of allergic asthma.

Exclusion criteria

Exclusion criteria: 1. Patients with immune deficiency diseases like AIDS, cancer etc 2. Patients with systemic illness that is contraindicated in spirometry (myocardial infarction, pneumothorax , large aneurysm etc). 3. Status asthmaticus 4. Pregnant and lactating mother

Design outcomes

Primary

Measure	Time frame
To measure the changes in FEV1/FVC ratio in allergic bronchial asthma patients before and after individualized homoeopathic medicinesTimepoint: ENROLLMENT PERIOD - 6 MONTHS FOLLOW UP PERIOD - 1 YEAR	—

Secondary

Measure	Time frame
1. To determine any significant reduction in serum IgE level in allergic bronchial asthma with individualised homoeopathic medicines 2. To find out changes in quality of life using Asthma Quality of life questionnaire with standardized activities AQLQ (s) 3. To find out changes in severity of asthma in Primary asthma control screening tool 4. To determine the frequency of inhaler used by patients with allergic asthma.Timepoint: ENROLLMENT PERIOD - 6 MONTHS FOLLOW UP PERIOD - 1 YEAR	—

Measure

Time frame

1. To determine any significant reduction in serum IgE level in allergic bronchial asthma with individualised homoeopathic medicines 2. To find out changes in quality of life using Asthma Quality of life questionnaire with standardized activities AQLQ (s) 3. To find out changes in severity of asthma in Primary asthma control screening tool 4. To determine the frequency of inhaler used by patients with allergic asthma.Timepoint: ENROLLMENT PERIOD - 6 MONTHS FOLLOW UP PERIOD - 1 YEAR

—

Countries

India

Contacts

Public ContactDr R SITHARTHAN

NATIONAL HOMOEOPATHIC RESEARCH INSTITUTE IN MENTAL HEALTH, KOTTAYAM

sitharthan.r@gmail.com9443203174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026